Similarly, YTHDF1 deficiency could inhibit NSCLC cell proliferation and xenograft tumor formation by regulating the translational efficiency of cell-cycle-related genes, such as CDK2, CDK4, and cyclin D1 [14]. The gene discussed is CDK4; the disease is neoplasm.